Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • 2018
  • Chapter
  • Location of Biopharmaceutical Activity

Are Licensing Markets Local? An Analysis of the Geography of Vertical Licensing Agreements in Bio-Pharmaceuticals

By: Juan Alcacer, John Cantwell and Michelle Gittelman
  • Format:Print
ShareBar

Abstract

As the value chain of the pharmaceutical industry disaggregates, upstream discovery is increasingly carried out by small research-specialized firms while downstream development, testing and marketing is conducted by global pharmaceutical firms. Licensing plays an important role in this emerging division of labor. Alcacer and his co-authors theorize that, similar to markets for upstream inputs such as scientific knowledge, proximity also may matter for licensing, which they conceptualize as downstream end markets for small biotechnology firms. They examine whether co-location affects the likelihood of vertical licensing transactions between biotechnology firms and global pharmaceutical firms. Discussions with industry executives indicate that large firms search globally for in-licensing opportunities and that licensing transactions should not be sensitive to the geographic locations of the transacting parties. However, an analysis of compounds developed by small biotechnology firms licensed to global pharmaceutical firms suggests that licensing transactions are more likely to occur between firms located in the same geographic area. The results point to the possibility that licensing markets are sensitive to the proximity of the partners, and that despite global search processes by multinationals in the pharmaceutical industry, licensing markets are localized.

Keywords

Geographic Location; Local Range; Rights; Research and Development; Biotechnology Industry; Pharmaceutical Industry

Citation

Alcacer, Juan, John Cantwell, and Michelle Gittelman. "Are Licensing Markets Local? An Analysis of the Geography of Vertical Licensing Agreements in Bio-Pharmaceuticals." In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. National Bureau of Economic Research, forthcoming.

About The Author

Juan Alcacer

Strategy
→More Publications

More from the Authors

    • December 2022
    • Faculty Research

    Iberdrola: Leading the Energy Revolution

    By: Juan Alcácer and Emer Moloney
    • December 2022 (Revised January 2023)
    • Faculty Research

    Circles.Life at a Crossroads of Growth

    By: Juan Alcacer and Adina Wong
    • November 2022
    • Faculty Research

    Introduction to the RC Strategy Course 2023

    By: Juan Alcacer
More from the Authors
  • Iberdrola: Leading the Energy Revolution By: Juan Alcácer and Emer Moloney
  • Circles.Life at a Crossroads of Growth By: Juan Alcacer and Adina Wong
  • Introduction to the RC Strategy Course 2023 By: Juan Alcacer
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College